| Indication | Drug Discovery | Preclinical | Clinical Phase 1 | Clinical Phase 2 | Clinical Phase 3 | Release |
|---|---|---|---|---|---|---|
| Obesity | ||||||
| Diabetes |
| Code | Indication | Drug Discovery | Preclinical | Clinical Study | Marketing Authorization | Release |
|---|---|---|---|---|---|---|
| DKF-310 | Dementia | |||||
| DKM-413 | Anesthetic | |||||
| DKM-412 | Osteoarthritis | |||||
| DKF-313 | Benign Prostatic Hyperplasia | |||||
| DKF-340 | NSAID | |||||
| DKF-361 | Hypertension | |||||
| DKF-363 | Respiratory Inflammation | |||||
| DKF-325 | Anticoagulant | |||||
| DKF-334 | Osteoporosis | |||||
| DKF-335 | Osteoporosis | |||||
| DKM-420 | Osteoarthritis | |||||
| DKM-415 | Synovial Fluid Replacement |
| Code | Indication | Drug Discovery | Preclinical | Clinical Study | Marketing Authorization | Release |
|---|---|---|---|---|---|---|
| DKB-119 | Biomaterials for tissue restoration | |||||
| DKM-410 | Biomaterials for tissue restoration |